1-14 of 14
Jair Bar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB107: Association of circulating free DNA (cfDNA) maximum variant allele frequency (mVAF) levels with clinical outcomes in patients (pts) with metastatic nonsquamous non-small cell lung cancer (NSCLC) treated with pembrolizumab (pembro) + chemotherapy (chemo) in the phase 2 KEYNOTE-782 trial

Jair Bar, Emilio Esteban, Delvys Rodríguez-Abreu, Santiago Ponce-Aix, Zsuzsanna Szalai, Enriqueta Felip, Maya Gottfried, Mariano Provencio Pulla, Andrew Robinson, Andrea Fülöp, Suman Bannur Rao, D. Ross Camidge, Giovanna Speranza, Nathan Hunkapiller, Robert McDaniel, Byoungsok Jung, David Burkhardt, Ruth Mauntz, Cai Chen, Carol Pena, Razvan Cristescu, Elisha J. Dettman, Steven M. Townson, Julie Kobie, Tibor Csőszi
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB107.
https://doi.org/10.1158/1538-7445.AM2024-LB107
Published: 05 April 2024
View article titled, Abstract LB107: Association of circulating free DNA (cfDNA) maximum variant allele frequency (mVAF) levels with clinical outcomes in patients (pts) with metastatic nonsquamous non-small cell lung cancer (NSCLC) treated with pembrolizumab (pembro) + chemotherapy (chemo) in the phase 2 KEYNOTE-782 trial
Journal Articles

Abstract 1208: Plasma proteomics-based models for predicting therapeutic benefit and immune-related adverse events in non-small cell lung cancer patients treated with immunotherapy

Michal Harel, Petros Christopoulos, Igor Puzanov, Jair Bar, Iris Kamer, Niels Reinmuth, Ina Koch, Mor Moskovitz, Adva Levy-Barda, Alona Zer, Michal Lotem, David Farrugia, Rivka Katzenelson, Gillian Price, Abed Agbarya, Helen Cheley, Adam Hassani, Mahmoud Abu-Amna, Tom Geldart, Anirban Chatterjee, Andreas Polychronis, Maya Gottfried, Yanyan Lou, Tatiana Harkovsky, Alison Brewster, Ido Wolf, Ella Tepper, Ben Yellin, Itamar Sela, Coren Lahav, Yehonatan Elon, Raya Leibowitz, Adam P. Dicker, Young Kwang Chae, Ryan J. Sullivan, David Carbone, David Gandara, Jarushka Naidoo
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1208.
https://doi.org/10.1158/1538-7445.AM2024-1208
Published: 22 March 2024
View article titled, Abstract 1208: Plasma proteomics-based models for predicting therapeutic benefit and immune-related adverse events in non-small cell lung cancer patients treated with immunotherapy
Journal Articles

Abstract 5522: Elucidating the role of P-selectin/P-selectin ligand-1 axis in lung cancer brain metastasis

Koren Salomon, Eilam Yeini, Neta Frommer, Irisi Kamer, Jair Bar, Iris Barshack, Ronit Satchi-Fainaro
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5522.
https://doi.org/10.1158/1538-7445.AM2024-5522
Published: 22 March 2024
View article titled, Abstract 5522: Elucidating the role of P-selectin/P-selectin ligand-1 axis in lung cancer brain metastasis
Journal Articles

Abstract CT216: Response to first-line (1L) pembrolizumab (pembro) + chemotherapy (chemo) in non-small cell lung cancer (NSCLC) by blood tumor mutational burden (bTMB): the phase 2 KEYNOTE-782 trial

Jair Bar, Emilio Esteban, Delvys Rodríguez-Abreu, Santiago Ponce Aix, Zsuzsanna Szalai, Enriqueta Felip, Maya Gottfried, Mariano Provencio Pulla, Andrew Robinson, Andrea Fülöp, Suman B. Rao, D. Ross Camidge, Giovanna Speranza, Steven M. Townson, Julie Kobie, Mark Ayers, Elisha J. Dettman, Robert McDaniel, Byoungsok Jung, David Burkhardt, Ruth Mauntz, Tibor Csőszi
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT216.
https://doi.org/10.1158/1538-7445.AM2023-CT216
Published: 14 April 2023
View article titled, Abstract CT216: Response to first-line (1L) pembrolizumab (pembro) + chemotherapy (chemo) in non-small cell lung cancer (NSCLC) by blood tumor mutational burden (bTMB): the phase 2 KEYNOTE-782 trial
Journal Articles

Abstract CT154: B-cell infiltration in lung cancer predicts response to neoadjuvant pembrolizumab

Jair Bar, Iris Kamer, Oranit Zadok, Damien Urban, Marina Perelman, Ilanit Redinsky, Aliza Ackerstein, Sameh Daher, Efrat Ofek, Amir Onn, Nona Zeitlin, Alon Ben-Nun, Ran Kremer, Inbal Daniel, Yossef Glantzspiegel, Irit Gat-Viks
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT154.
https://doi.org/10.1158/1538-7445.AM2022-CT154
Published: 15 June 2022
View article titled, Abstract CT154: B-cell infiltration in lung cancer predicts response to neoadjuvant pembrolizumab
Journal Articles

Abstract CT179: Telisotuzumab vedotin (teliso-v) monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer

D. Ross Camidge, Fedor Moiseenko, Irfan Cicin, Hidehito Horinouchi, Elena Filippova, Jair Bar, Shun Lu, Pascale Tomasini, Christopher Ocampo, Danielle Sullivan, David Maag, Jonathan W. Goldman
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT179.
https://doi.org/10.1158/1538-7445.AM2021-CT179
Published: 01 July 2021
View article titled, Abstract CT179: Telisotuzumab vedotin (teliso-v) monotherapy in patients with previously treated c-Met<sup>+</sup> advanced non-small cell lung cancer
Journal Articles

Abstract CT223: Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates

Benjamin Solomon, Enriqueta Felip, Jair Bar, Guy Berchem, Lyudmila Bazhenova, Pierre Saintigny, Nicolas Girard, Raed Sulaiman, Catherine Bresson, Fanny Wunder, J Jack Lee, Jacques Raynaud, Eitan Rubin, Brandon Young, Vladimir Lazar, Amir Onn, Brian Leyland Jones, Razelle Kurzrock
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT223.
https://doi.org/10.1158/1538-7445.AM2019-CT223
Published: 01 July 2019
View article titled, Abstract CT223: Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates
Journal Articles

Abstract 4910: Modeling immunotherapy in ex vivo organ culture of non-small cell lung cancer (NSCLC)

Jair Bar, Inbal Daniel-Meshulam, Amir Onn, Alon Ben-Nun, David Simansky, Nona Zeitlin, Nir Golan, Meirav Rokah, Ronni Ben-Avi, Iris Kamer
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4910.
https://doi.org/10.1158/1538-7445.AM2016-4910
Published: 15 July 2016
View article titled, Abstract 4910: Modeling immunotherapy in <em>ex vivo</em> organ culture of non-small cell lung cancer (NSCLC)
Journal Articles

Abstract 3721: Rapid widening of age and race health disparities in prostate cancer outcomes within the United States, 1973-2014

Richard J. Lawrence, Damien Urban, Talia Golan, Akram Saad, Raanan Berger, Raya Leibowitz-Amit, Jair Bar, Robert Den, Jeffrey Goldstein, Zvi Symon
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3721.
https://doi.org/10.1158/1538-7445.AM2015-3721
Published: 01 August 2015
View article titled, Abstract 3721: Rapid widening of age and race health disparities in prostate cancer outcomes within the United States, 1973-2014
Journal Articles

Abstract 1153: Stromal FoxM1 and p53 in lung cancer as mediators of tumor progression, metastatic spread and chemo-resistance

Iris Kamer, Inbal Daniel, Gili Perry, Amir Onn, Jair Bar
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1153.
https://doi.org/10.1158/1538-7445.AM2014-1153
Published: 01 October 2014
View article titled, Abstract 1153: Stromal FoxM1 and p53 in lung cancer as mediators of tumor progression, metastatic spread and chemo-resistance
Journal Articles

Abstract 895: Activating transcription factor 3 (ATF3) down-regulation correlates with platinum resistance in non-small cell lung cancer (NSCLC).

Jair Bar, Ivan Gorn-Hondermann, Reid Stephanie, Patricia Moretto, Iris Shiran, Shlomit Jessel, Marina Perelman, Eyal Heller, Iris Kamer, Inbal Daniel-Meshulam, Glenwood D. Goss, Jim Dimitroulakos
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 895.
https://doi.org/10.1158/1538-7445.AM2013-895
Published: 15 April 2013
View article titled, Abstract 895: Activating transcription factor 3 (ATF3) down-regulation correlates with platinum resistance in non-small cell lung cancer (NSCLC).
Journal Articles

Abstract 4949: microRNA (miR) analysis as a tool for discovering platinum resistance mechanisms in non-small cell lung cancer (NSCLC)

Jair Bar, Carolina Perez-Iratxeta, Ivan Gorn-hundermann, Reid Stefanie, Glenwood D. Goss, Jim Dimitroulakos
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4949.
https://doi.org/10.1158/1538-7445.AM2011-4949
Published: 15 April 2011
View article titled, Abstract 4949: microRNA (miR) analysis as a tool for discovering platinum resistance mechanisms in non-small cell lung cancer (NSCLC)
Journal Articles

p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts

Neta Moskovits, Alexander Kalinkovich, Jair Bar, Tsvee Lapidot, Moshe Oren
Journal: Cancer Research
Cancer Res (2006) 66 (22): 10671–10676.
https://doi.org/10.1158/0008-5472.CAN-06-2323
Published: 15 November 2006
View article titled, p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts
Open the PDF for p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts in another window
Journal Articles

Nuclear Factor-κB Protects the Liver against Genotoxic Stress and Functions Independently of p53

Iris Lavon, Eli Pikarsky, Elena Gutkovich, Iris Goldberg, Jair Bar, Moshe Oren, Yinon Ben-Neriah
Journal: Cancer Research
Cancer Res (2003) 63 (1): 25–30.
Published: 01 January 2003
View article titled, Nuclear Factor-κB Protects the Liver against Genotoxic Stress and Functions Independently of p53
Open the PDF for Nuclear Factor-κB Protects the Liver against Genotoxic Stress and Functions Independently of p53 in another window